Anika Therapeutics - ANIK Profit before deduction of interest, taxes, depreciation and amortization
Steady demand for regenerative technologies provides Anika Therapeutics (ANIK) with a sustainable cash flow. The company's EBITDA reflects profit dynamics where the 3.05 mark serves as a key metric. Growth is driven by expansion in the B2B supply segment for surgeons, while revenue relies on demographic aging and the availability of insurance payouts for patients.
Summary analytical data breakdowns for Anika Therapeutics (ANIK)
- stock value and consensus price forecast:
- issuer market value details:
- book capitalization indicators:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Anika Therapeutics|ANIK - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Anika|ANIK - Company Aggregate Debts|Debts to Book Value Anika Therapeutics, Inc.|ANIK - Company Long-Term Debts|Company Short-Term Indebtedness Anika Therapeutics|Interim Coverage Ratio anikatherapeutics.com
- earnings and market multiples details:
ANIK - Net Profit|Future Profit Anika Therapeutics|ANIK - P/E Multiple|Forward P/E Multiple Anika Therapeutics|ANIK - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Anika|ANIK - Operating profit before deduction of amortization|Earnings per share for the trailing year Anika Therapeutics|ANIK - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months anikatherapeutics.com|ANIK - Earnings per share growth in current year|Net earnings per one share growth forecast for next year Anika Therapeutics
- sales revenue and business income indicators:
Summary company analytics:Anika Therapeutics
This indicator measures the daily cash volume generated by core business operations before depreciation and interest, reflecting the actual efficiency of the operating cycle. A professional investor analyzes the current EBITDA to assess the ability of Anika Therapeutics (ANIK) to fund the transition to innovative implants and sports medicine through its own cash flow.
Who Anika Therapeutics competes with
BSX (Boston Scientific) - Profit before deduction of interest, taxes, depreciation and amortization|Edwards Lifesciences Corp - Operating profit EBITDA|Profit before interest, taxes and amortization ResMed|PODD: Operating profit EBITDA|Operating profit before amortization ZBH|Operating profit before deduction of amortization COO|Operating profit before amortization ALGN (Align Technology)|Operating profit before deduction of amortization GMED (Globus Medical)|TMDX (TransMedics Corp) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Alphatec Corp ATEC|AORT - Operating profit before deduction of amortization|Enovis Corp - Operating profit EBITDA|Profit before interest, taxes and amortization Integra LifeSciences|ESTA: Operating profit EBITDA|Operating profit before amortization BBNX|IRMD (IRADIMED Inc.) - Operating profit EBITDA|Embecta Inc. (EMBC) - Operating income before deduction of amortization|Operating profit EBITDA TNDM|Operating profit before deduction of amortization AxoGen, Inc. AXGN|Operating profit EBITDA SIBN (si-bone.com)|Operating profit EBITDA Orthofix Medical OFIX|BVS: Operating profit before deduction of amortization|KIDS: Profit before payment of interest, taxes and amortization|TMCI (Treace Medical Concepts) - Operating profit before deduction of amortization|Strata Critical Medical Inc - Income before deduction of interest, taxes and amortization|CARL (Carlsmed Medical) - Operating profit EBITDA|Profit before interest, taxes and amortization RxSight Inc RXST|Profit before payment of interest, taxes and amortization ClearPoint Neuro (CLPT)|Stereotaxis, Inc. (STXS) - Operating profit before depreciation charges|Neuronetics, Inc - Operating profit before deduction of amortization|Operating profit EBITDA Sight Sciences, Inc. SGHT|Orchestra BioMed Inc. - Operating profit EBITDA|Operating income before deduction of amortization InspireMD Inc NSPR|Jin Medical (ZJYL) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization VANI (Vivani)|Profit before payment of interest, taxes and amortization xtantmedical.com|Operating profit before deduction of amortization NeuroOne Medical Technologies (NMTC)|Operating profit EBITDA MODD|Myomo, Inc - Operating profit before amortization|Profit before payment of interest, taxes and amortization Envoy Medical, Inc. COCH|VVOS: Operating profit before amortization|NVNO: Operating profit before deduction of amortization|Sintx Technologies, Inc. - Company profit before taxes, interest and amortization|TNON (Tenon Medical, Inc.) - Operating profit before deduction of amortization|Lifeward - Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization AMIX|Profit before payment of interest, taxes and amortization IVF|Profit before payment of interest, taxes and amortization Bone Biologics Corp (BBLG)|AXNX - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization BIOLASE BIOL|Operating profit EBITDA dynatronics.com DYNT|FNA - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization INVO (invobioscience.com)
